aTYR PHARMA INC (ATYR) bonds
ATYRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$4.08−0.91 (-18.24%)
Close on Nov 18, 2026Market cap $400.20MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
aTYR PHARMA reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in aTYR PHARMA's 10-K for the period ended Dec 31, 2017
aTYR PHARMA's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| Term Loan Agreement Tranche One | $10.00M |
| Term Loan Agreement Tranche Three | $5.00M |
| Term Loan Agreement Tranche Two | $5.00M |
See a number that looks wrong?